Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101--Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent tr (Q33973013)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101--Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent tr	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101--Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent tr (English)

1 reference

Europe PubMed Central

30 July 2017

0 references

pharmacotherapy

0 references

0 references

placebo-controlled trial

1 reference

based on heuristic

inferred from title

Justin Ezekowitz

object named as

Justin Ezekowitz

5

0 references

author name string

Edith Pituskin

1

1 reference

Europe PubMed Central

30 July 2017

Mark Haykowsky

2

1 reference

Europe PubMed Central

30 July 2017

John R Mackey

3

1 reference

Europe PubMed Central

30 July 2017

Richard B Thompson

4

1 reference

Europe PubMed Central

30 July 2017

Sheri Koshman

6

1 reference

Europe PubMed Central

30 July 2017

Gavin Oudit

7

1 reference

Europe PubMed Central

30 July 2017

Kelvin Chow

8

1 reference

Europe PubMed Central

30 July 2017

Joseph J Pagano

9

1 reference

Europe PubMed Central

30 July 2017

Ian Paterson

10

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

27 July 2011

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

11

1 reference

Europe PubMed Central

30 July 2017

318

1 reference

Europe PubMed Central

30 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-11-318

0 references

Role of biomarkers in chemotherapy-induced cardiotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Biomarkers in heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Genomics in cardiac metabolism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Early breast cancer therapy and cardiovascular injury.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

A meta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Protective effects of carvedilol against anthracycline-induced cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

A systematic review: effect of angiotensin converting enzyme inhibition on left ventricular volumes and ejection fraction in patients with a myocardial infarction and in patients with left ventricular dysfunction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Mechanisms and models in heart failure: the biomechanical model and beyond

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

The tumor metabolome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

A clinicopathologic analysis of adriamycin cardiotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171383

5 July 2018

Phase II study of efficacy, safety, and pharmacokinetics of trastuzumab monotherapy administered on a 3-weekly schedule.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Left ventricular volume measurement with echocardiography: a comparison of left ventricular opacification, three-dimensional echocardiography, or both with magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Stu

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Circulating biomarkers of collagen metabolism in cardiac diseases

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Transcriptomic and proteomic analysis in the cardiovascular setting: unravelling the disease?

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-318

21 January 2018

Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/21794114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21794114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21794114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Magnetic resonance imaging in cardiology

1 reference

https://pubmed.ncbi.nlm.nih.gov/21794114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/21794114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21794114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Troponin I and cardiovascular risk stratification in patients with testicular cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21794114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiotoxicity of trastuzumab in clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21794114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum Carboxy-Terminal Propeptide of Procollagen Type I Is a Marker of Myocardial Fibrosis in Hypertensive Heart Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21794114

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-11-318

1 reference

Europe PubMed Central

30 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33973013&oldid=1639614055"